Alseres Pharmaceuticals, Inc.

Alseres Pharmaceuticals, Inc.

Alseres Pharmaceuticals, Inc. was founded in 1972 and is headquartered in Hopkinton, Massachusetts. The biotechnology company is developing therapies and diagnostics related to nervous system conditions, such as spinal cord injury, Parkinson's disease, and attention deficit hyperactivity disorder (ADHD). Its lead candidate is Altropane, a molecular imaging agent for diagnosing Parkinson's disease and ADHD. Another candidate, Cethrin, aims to repair nerve damage caused by spinal cord injury; Alseres licensed Cethrin from Canadian firm BioAxone Therapeutic in 2006.

Contact Details

Office Address

Alseres Pharmaceuticals, Inc.
239 South Street
Hopkinton, MA, USA 01748
Phone: (508) 497-2360
Fax: (508) 497-9964

Executives

Exec. Chairman & Chief Exec. Officer

Mr. Peter G. Savas

Pres and Chief Operating Officer

Dr. Mark Jerome Pykett

Business Reviews for Alseres Pharmaceuticals, Inc.

Related Companies